Palisades Investment Partners, LLC Adma Biologics, Inc. Transaction History
Palisades Investment Partners, LLC
- $237 Billion
- Q4 2024
A detailed history of Palisades Investment Partners, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Palisades Investment Partners, LLC holds 400,663 shares of ADMA stock, worth $6.35 Million. This represents 2.9% of its overall portfolio holdings.
Number of Shares
400,663
Previous 349,005
14.8%
Holding current value
$6.35 Million
Previous $6.98 Billion
1.51%
% of portfolio
2.9%
Previous 3.04%
Shares
3 transactions
Others Institutions Holding ADMA
# of Institutions
339Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$295 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$288 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$236 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$179 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$87.7 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.11B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...